Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects Author Name Martin Kankam et al Category Computer science, information & general works Type Journal Tags efficacy,Hepatitis A Virus,Infectious diseases,Intramuscular immunoglobulin,Pharmacokinetics,safety,Tolerability Login to Access Content
